The Cystic Fibrosis Foundation has increased its award to Arcturus Therapeutics to up to $15 million to develop a mutation-agnostic therapy for people with cystic fibrosis.
Aug. 5, 2019
|
2 min read
Dec. 29, 2009
|
2 min read
Dec. 22, 2009
|
2 min read
Dec. 15, 2009
|
2 min read
Nov. 2, 2009
|
3 min read
Oct. 15, 2009
|
1 min read
Sept. 22, 2009
|
3 min read
Aug. 18, 2009
|
2 min read
Aug. 13, 2009
|
2 min read